Distribution of histone3 lysine 4 trimethylation at T3-responsive loci in the heart during reversible changes in gene expression

Gene Expression

Volumn 15, Issue 4, 2012, Pages 183-198

  Pandya, Kumar ^a   Kohro, Takahide ^b   Mimura, Imari ^b   Kobayashi, Mika ^b   Wada, Youichiro ^b   Kodama, Tatsuhiko ^b   Smithies, Oliver ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

ChIP seq; Epigenetic; Heart; Histone methylation; Myosin heavy chain; Thyroid hormone

Indexed keywords

HISTONE 3 LYSINE 4; MYOSIN HEAVY CHAIN BETA; NUCLEAR PROTEIN; THYROID HORMONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; GENE LOCUS; HEART VENTRICLE; HISTONE METHYLATION; HISTONE MODIFICATION; MOUSE; NONHUMAN; PROTEIN LOCALIZATION;

ADMINISTRATION, ORAL; ANIMALS; ANTITHYROID AGENTS; BINDING SITES; BIOLOGICAL MARKERS; CHROMATIN IMMUNOPRECIPITATION; DNA, INTERGENIC; EPIGENESIS, GENETIC; GENE EXPRESSION; GENETIC LOCI; HEART VENTRICLES; HISTONES; METHYLATION; MICE; MYOSIN HEAVY CHAINS; PROPYLTHIOURACIL; PROTEIN BINDING; REGULATORY SEQUENCES, RIBONUCLEIC ACID; TRIIODOTHYRONINE;

MUS;

EID: 84863083797     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: 10.3727/105221612X13372578119698     Document Type: Article

References (31)

1. Adamson, C.; Maitra, N.; Bahl, J.; Greer, K.; Klewer, S.; Hoying, J.; Morkin, E. Regulation of gene expression in cardiomyocytes by thyroid hormone and thyroid hormone analogs 3,5-diiodothyropropionic acid and CGS 23425 [N-[3,5-dimethyl-4-(4′-hydroxy-3′- isopropylphenoxy)-phenyl]-oxamic acid]. J. Pharmacol. Exp. Ther. 311:164-171; 2004.
2. Aranda, A.; Pascual, A. Nuclear hormone receptors and gene expression. Physiol. Rev. 81:1269-1304; 2001.
3. Dillmann, W. H. Cellular action of thyroid hormone on the heart. Thyroid 12: 447-452; 2002.
4. Giger, J.; Qin, A. X.; Bodell, P. W.; Baldwin, K. M.; Haddad, F. Activity of the beta-myosin heavy chain antisense promoter responds to diabetes and hypothyroidism. Am. J. Physiol. Heart Circ. Physiol. 292: H3065-3071; 2007.
5. Giger, J. M.; Bodell, P. W.; Baldwin, K. M.; Haddad, F. The CAAT-binding transcription factor 1/nuclear factor 1 binding site is important in beta-myosin heavy chain antisense promoter regulation in rats. Exp. Physiol. 94:1163-1173; 2009.
6. Guenther, M. G.; Levine, S. S.; Boyer, L. A.; Jaenisch, R.; Young, R. A. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130:77-88; 2007.
7. Haddad, F.; Bodell, P. W.; Qin, A. X.; Giger, J. M.; Baldwin, K. M. Role of antisense RNA in coordinating cardiac myosin heavy chain gene switching. J. Biol. Chem. 278:37132-37138; 2003.
8. Haddad, F.; Jiang, W.; Bodell, P. W.; Qin, A. X.; Baldwin, K. M. Cardiac myosin heavy chain gene regulation by thyroid hormone involves altered histone modifications. Am. J. Physiol. Heart Circ. Physiol. 299:H1968-1980; 2010.
9. Haddad, F.; Qin, A. X.; Bodell, P. W.; Zhang, L. Y.; Guo, H.; Giger, J. M.; Baldwin, K. M. Regulation of antisense RNA expression during cardiac MHC gene switching in response to pressure overload. Am. J. Physiol. Heart Circ. Physiol. 290:H2351-2361; 2006.
10. Ishihara, K.; Oshimura, M.; Nakao, M. CTCF-dependent chromatin insulator is linked to epigenetic remodeling. Mol. Cell 23:733-42; 2006.
11. Kahaly, G. J.; Dillmann, W. H. Thyroid hormone action in the heart. Endocr. Rev. 26:704-728; 2005.
12. Kim, J.; Daniel, J.; Espejo, A.; Lake, A.; Krishna, M.; Xia, L.; Zhang, Y.; Bedford, M. T. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep. 7:397-403; 2006.
13. Kimura, H.; Hayashi-Takanaka, Y.; Goto, Y.; Takizawa, N.; Nozaki, N. The organization of histone H3 modifications as revealed by a panel of specific monoclonal antibodies. Cell Struct. Funct. 33:61-73; 2008.
14. Kouzarides, T. Chromatin modifications and their function. Cell 12:693-705; 2007.
15. Le Bouter, S.; Demolombe, S.; Chambellan, A.; Bellocq, C.; Aimond, F.; Toumaniantz, G.; Lande, G.; Siavoshian, S.; Baro, I.; Pond, A. L.; Nerbonne, J. M.; Leger, J. J.; Escande, D.; Charpentier, F. Microarray analysis reveals complex remodeling of cardiac ion channel expression with altered thyroid status relation to cellular and integrated electrophysiology. Circ. Res. 92: 234-242; 2003.
16. Lee, B. M.; Mahadevan, L. C. Stability of histone modifications across mammalian genomes implications for 'epigenetic' marking. J. Cell. Biochem. 108:22-34; 2009.
17. Li, B.; Carey, M.; Workman, J. L. The role of chromatin during transcription. Cell 128:707-719; 2007.
18. Mellor, J.; Dudek, P.; Clynes, D. A glimpse into the epigenetic landscape of gene regulation. Curr. Opin. Genet. Dev. 18:116-122; 2008.
19. Mendenhall, E. M.; Bernstein, B. E. Chromatin state maps new technologies, new insights. Curr. Opin. Genet. Dev. 18:109-115; 2008.
20. Pandya, K.; Pulli, B.; Bultman, S.; Smithies, O. Reversible epigenetic modifications of the two cardiac myosin heavy chain genes during changes in expression. Gene Expr. 15:51-59; 2011.
21. Portman, M. A. Thyroid hormone regulation of heart metabolism. Thyroid 18:217-225; 2008.
22. Rundell, V. L.; Manaves, V.; Martin, A. F.; de Tombe, P. P. Impact of beta-myosin heavy chain isoform expression on cross-bridge cycling kinetics. Am. J. Physiol. Heart Circ. Physiol. 288:H896-903; 2005.
23. Saitoh, N.; Bell, A. C.; Recillas-Targa, F.; West, A. G.; Simpson, M.; Pikaart, M.; Felsenfeld, G. Structural and functional conservation at the boundaries of the chicken beta-globin domain. EMBO J. 19:2315-2322; 2000.
24. Santos-Rosa, H.; Schneider, R.; Bannister, A. J.; Sherriff, J.; Bernstein, B. E.; Emre, N. C.; Schreiber, S. L.; Mellor, J.; Kouzarides, T. Active genes are tri-methylated at K4 of histone H3. Nature 419:407-411; 2002.
25. Seila, A. C.; Calabrese, J. M.; Levine, S. S.; Yeo, G. W.; Rahl, P. B.; Flynn, R. A.; Young, R. A.; Sharp, P. A. Divergent transcription from active promoters. Science 322:1849-1851; 2008.
26. van Rooij, E.; Sutherland, L. B.; Qi, X.; Richardson, J. A.; Hill, J.; Olson, E. N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316:575-579; 2007.
27. Wada, H.; Hashimoto, K.; Wada, Y.; Kobayashi, M.; Izumi, A.; Sugiyama, A.; Kohro, T.; Hamakubo, T.; Kodama, T. Extensive oligonucleotide microarray transcriptome analysis of the rat cerebral artery and arachnoid tissue. J. Atheroscler. Thromb. 9:224-232; 2002.
28. Wada, Y.; Ohta, Y.; Xu, M.; Tsutsumi, S.; Minami, T.; Inoue, K.; Komura, D.; Kitakami, J.; Oshida, N.; Papantonis, A.; Izumi, A.; Kobayashi, M.; Meguro, H.; Kanki, Y.; Mimura, I.; Yamamoto, K.; Mataki, C.; Hamakubo, T.; Shirahige, K.; Aburatani, H.; Kimura, H.; Kodama, T.; Cook, P. R.; Ihara, S. A wave of nascent transcription on activated human genes. Proc. Natl. Acad. Sci. USA 106:18357-18361; 2009.
29. Wang, Z.; Zang, C.; Rosenfeld, J. A.; Schones, D. E.; Barski, A.; Cuddapah, S.; Cui, K.; Roh, T. Y.; Peng, W.; Zhang, M. Q.; Zhao, K. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat. Genet. 40:897-903; 2008.
30. Yen, P. M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81:1097-1142; 2001.
31. Zecchini, V.; Mills, I. G. Putting chromatin immunoprecipitation into context. J. Cell. Biochem. 107:19-29; 2009.